Check out the latest in cluster headache research!
- June 9, 2016
The main purpose of this study is to assess the long-term safety and tolerability of galcanezumab administered up to once monthly in participants with episodic or chronic cluster headache who have completed study I5Q-MC-CGAL (NCT02397473) or study I5Q-MC-CGAM (NCT02438826).
- May 12, 2016
Study of Deep Brain Stimulation of the Third ventricle in Cluster Headache and Obesity treatment.
- November 30, 2015
The purpose of this non-confirmatory study is to determine if SOM230 has adequate efficacy and safety to warrant further clinical development in cluster headache (CH). This study will have two parts. Part A will be a parallel design SOM230 vs. Placebo, and following an observed signal in Part A at an interim analysis, Part B ...
- May 21, 2015
This study aims to explore the relationship between CGRP and episodic cluster headache, both during cycles and remission periods.
Pathway CH S&E Registry: Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache – ATI Neurostimulation System is Branded Internationally as Pulsante™ Microstimulator SystemMay 6, 2015
Monitor the safety and performance of the Pulsante Microstimulator System.
- May 6, 2015
The main purpose of this study is to evaluate the efficacy of the study drug known as LY2951742 in participants with chronic cluster headache.